No Data
Medilex has been found to have a Shareholding of over 5% in Long Corridor.
It has been revealed that Long Corridor Asset Management (Long Corridor) holds more than 5% of Medrex<4586.T>'s Stocks. According to the large shareholder report submitted by Long Corridor after the market closed on the 17th, the company holds 12.3 million shares (shareholding ratio of 20.72%). The purpose of the shareholding is for pure investment. The closing price on the 17th was 61 yen, down 1 yen from the previous day. Provided by Wealth Advisor Inc.
Express News | The Long Corridor reported a shareholding of 20.72% in Medrex (4586.JP).
Stocks that moved and those that were traded in the front market.
*Shinkong Electric Industry <6967> 8781 +1176, the buying back situation is still leading. *GMO Internet <4784> 1470 +141, updating highs, and moving lightly within domestic stocks for price range opportunities. *KADOKAWA <9468> 3838 +224, a subsidiary announced a new product for Switch 2. *United Arrows <7606> 2244 +126, the same-store sales for March had double-digit revenue growth. *Nishimatsuya Options Chain <7545>
Medrex rebounded after eight days, as the FDA accepted the application for a neuropathic pain treatment drug co-developed with DWTI.
Medrex <4586.T> rebounded for the first time in eight days after a period of no change, temporarily reaching 77 yen, which is an increase of 9 yen. After the close on the 2nd, the company announced that its group and De-Western Therapeutics Institute (DWTI) <4576.T> had resubmitted an application for new drug approval to the FDA (U.S. Food and Drug Administration) for the treatment of postherpetic neuralgia "MRX-5LBT," and it was accepted, which is viewed as noteworthy. According to the company, "MRX-5LBT" utilizes ionic liquids.
D. Western Therapeutics' Lidocaine Patch NDA Accepted by FDA
A soft trend with selling first, but a solid performance at lower prices may occur.
[Emerging Markets Individual Stock Strategy] The Emerging Markets are expected to have a weak performance today. In yesterday's U.S. stock market on the 2nd, the Dow Inc gained 235.36 dollars (+0.56%) to close at 42,225.32 dollars. Selling pressure continued as concerns over the Trump administration's announcement of reciprocal tariffs weighed on stock prices. On the other hand, the private sector ADP Employment Statistics reported growth that exceeded Financial Estimates, leading to increased buying as fears of an economic downturn eased. Additionally, the highest tariff rates were announced, with plans to lower them depending on subsequent negotiations.